Kann ein einfaches geriatrisches Assessment das TURP-Ergebnis vorhersagen?

Autor: Madersbacher, S., Eredics, K., Gschliesser, T., Lodeta, B., Heißler, O., Kunit, T., Meyer, C.

Publikováno v: 46. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; 20200514-20200516; Nürnberg; DOC20urobay018 /20200730/

Einleitung: Der demographische Wandel führt zu einer kontinuierlich steigenden Zahl von betagten Patienten mit Harnretention. Das Ziel dieser Studie war zu evaluieren, ob ein einfaches geriatrisches Assessment das TURP-Ergebnis von betagten Patiente

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d9bfa30b0bc5240debb9aca9277115b
http://nbn-resolving.de/urn:nbn:de:0183-20urobay0188

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study.

Autor: Dieckmann KP; Department of Urology, Hodentumorzentrum, Asklepios Klinik Altona, Paul Ehrlich Straße 1, 22763 Hamburg, Germany., Pokrivcak T; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Masaryk University, Brno, Czech Republic., Geczi L; National Institute of Oncology, Budapest, Hungary., Niehaus D; Department of Urology, Asklepios Klinik Altona, Hamburg, Germany., Dralle-Filiz I; Department of Urology, Albertinen-Krankenhaus, Hamburg, Germany., Matthies C; Department of Urology, Bundeswehrkrankenhaus Hamburg, Hamburg, Germany., Dienes T; National Institute of Oncology, Budapest, Hungary., Zschäbitz S; Department of Medical Oncology, Universitätsklinikum Heidelberg, Heidelberg, Germany., Paffenholz P; Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University Hospital Cologne, Cologne, Germany., Gschliesser T; Department of Urology, Klinikum Klagenfurt, Klagenfurt, Austria., Pichler R; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Mego M; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic., Bader P; Department of Urology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany., Zengerling F; Department of Urology, Universitätsklinikum Ulm, Ulm, Germany., Heinzelbecker J; Department of Urology and Pediatric Urology, University Medical Centre, Saarland University, Homburg/Saar, Germany., Krausewitz P; Department of Urology and Pediatric Urology, Universitätsklinikum Bonn, Bonn, Germany., Krege S; Department of Urology, Evangelische Kliniken Essen-Mitte, Essen, Germany., Aurilio G; Medical Oncology Division of Urogenital and Head and Neck Tumours, IEO, European Institute of Oncology IRCCS, Milan, Italy., Aksoy C; Klinik und Poliklinik für Urologie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Hentrich M; Department of Hematology and Oncology, Red Cross Hospital, Munich, Germany., Seidel C; Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Törzsök P; Department of Urology and Andrology, Paracelsus Medical University Salzburg, Salzburg, Austria., Nestler T; Department of Urology, Bundeswehrzentralkrankenhaus Koblenz, Koblenz, Germany., Majewski M; Department of Urology, Bundeswehrkrankenhaus Ulm, Ulm, Germany., Hiester A; Department of Urology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Buchler T; Department of Oncology, Charles University and Thomayer Hospital, Prague, Czech Republic., Vallet S; Department of Internal Medicine II, Universitätsklinikum Krems, Krems, AustriaDepartment of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic., Studentova H; Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic., Schönburg S; Department of Urology, Universitätsklinikum Halle (Saale), Halle (Saale), Germany., Niedersüß-Beke D; Department of Medical Oncology, Wilhelminenspital, Vienna, Austria., Ring J; Department of Urology, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany., Trenti E; Department of Urology, Central Hospital Bolzano, Bolzano, Italy., Heidenreich A; Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University Hospital Cologne, Cologne, Germany., Wülfing C; Department of Urology, Asklepios Klinik Altona, Hamburg, Germany., Isbarn H; Martini-Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Pichlmeier U; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Pichler M; Division of Oncology, Medical University of Graz, Graz, Austria.

Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Mar 31; Vol. 14, pp. 17588359221086813. Date of Electronic Publication: 2022 Mar 31 (Print Publication: 2022).

Wie exakt ist die Fusionsbiopsie der Prostata im Vergleich zu einer systematischen 12-Zylinder Prostatabiopsie in Diagnosestellung und Charakterisierung des Prostatakarzinoms?

Autor: Berger, I., Steiner, E., Csomorova, K., Gschliesser, T., Stoiber, C., Beneder, R., Hofbauer, J.

Publikováno v: 43. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; 20170518-20170520; Wien; DOC17oegu016 /20170403/

Ziel: Das Ziel der vorliegenden Arbeit war es, prospektiv die Ergebnisse der Prostatabiopsien zwischen der transrektalen mp MRI/TRUS Fusionsbiopsie (FB) unter Verwendung des Biojet® Systems und der systematischen 12-Zylinder transrektalen Standardbi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb23d59d2bb11cda394341b4ec576f13
http://nbn-resolving.de/urn:nbn:de:0183-17oegu0160

Can a Simple Geriatric Assessment Predict the Outcome of TURP?

Autor: Eredics K; Department of Urology, Donauspital, Vienna, Austria, klaus.eredics@gmail.com., Meyer C; Department of Urology, Kaiser Franz Josef Hospital, Vienna, Austria., Gschliesser T; Department of Urology, Klinikum Klagenfurt, Vienna, Austria., Lodeta B; Department of Urology, Klinikum Klagenfurt, Vienna, Austria., Heissler O; Department of Urology, Landesklinikum Baden-Mödling, Vienna, Austria., Kunit T; Department of Urology, Paracelsus Medical University Salzburg, Vienna, Austria., Madersbacher S; Department of Urology, Kaiser Franz Josef Hospital, Vienna, Austria.; Department of Urology, Sigmund Freud Private University, Vienna, Austria.

Publikováno v: Urologia internationalis [Urol Int] 2020; Vol. 104 (5-6), pp. 367-372. Date of Electronic Publication: 2020 Apr 01.

100 - The impact of gender on tumour stage, in house complications and choice of urinary diversion – results of the Austrian Cystectomy Registry

Autor: Gschliesser, T., Madersbacher, S.

Publikováno v: In European Urology Supplements December 2016 15(11):e1473-e1473